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Summary: We describe a laboratory assessment of five blood glucose meters. The instruments' analytical
characteristics under optimum laboratory conditions and examination of potential sources of errors were
intercompared. All glucometers produced precise results, and in all but one meter the CV values varied
between 1.5% and 6%. CV's for reproducibility and within-day precision of Glucometer Gx were 10.5% and
7.3%. Sample volume, blood incubation time and colour stability of the strip may influence the results of
blood glucose measurements with glucose meters. Underloading the sample strip had statistically significant
effects on normal blood glucose values for all meters. One Touch II gave also significantly different results
when the strip was overloaded. Incubation times shorter or longer than those recommended by the manufac-
turer influenced the results of all glucose meters. After colour development of the strip, changes were small
for Haemo-Glukotest 20-800R strips and Glucotrix, whereas Accutrend glucose strips had to be read
immediately following the prescribed incubation time. Comparison of the glucose meter results with those
obtained by the hexokinase method showed good correlation coefficients for Reflolux S (r = 0.992), Accutrend
(r = 0.988), One Touch II (r = 0.942), Glucometer Gx (r = 0.986) and Glucocard (r = 0.976). Error grid
analysis showed that the results of all meters were clinically correct. Variations in haematocrit are known to
be a source of errors when blood glucose is determined with a test strip. In the normoglycaemic range the
results obtained with Accutrend and Glucocard were not influenced by even extreme haematocrit values. In
the high glucose concentration range there was a decrease in blood glucose values with increasing haematocrit
for all meters. This error was smaller with Accutrend and Glucocard than with the other meters.
Although the new versions of the monitors are easier to use, their analytical performance is not superior to
earlier models.
Introduction
Self-monitoring of blood glucose concentrations is a
common practice in the routine management of dia-
betic patients (1).
Several devices are now available for monitoring glu-
cose concentration in whole blood. Visually readable
strips and reflectance photometers are widely used.
While glucose determination by means of visual as-
sessment of the test strips is limited to range-related
comparison of developed colour, blood glucose meters
are able to display continuous values. The reflectance
photometers have undergone extensive modification
reflectance photometers of several manufacturers are
on the market. We assessed the performance of five
such instruments:
Reflolux S (Boehringer Mannheim Canada Ltd., Dor-
val, Quebec),
Accutrend (Boehringer Mannheim Canada Ltd, Dor-
val, Quebec),
One Touch II (Lifescan Inc., Mountain View, CA
94043),
Glucometer Gx (Arnes Division, Miles Laboratories,
in the past few years, and "improved versions" of Etobicoke, Ontario) and
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Glucocard (Menarini Diagnostics, DIG Kyoto, Ka-
gaku Co. Ltd. Japan).
Although an evaluation of these instruments under
working conditions (bedside or ambulatory monitor-
ing) is certainly preferable, this is hard to carry out
due to logistic (sample volume needed to perform all
the experiments) and ethical restraints (numerous
punctures, duration of the examination). We chosen,
therefore, to examine the instruments under optimum
laboratory conditions. The analytical characteristics
of five instruments were intercompared and compar-
ison between the results obtained with these five mon-
itors and a laboratory reference method was made as
well.
Materials and Methods
Materia ls , samples
Blood from one healthy volunteer was used to reach a sample
volume large enough to perform all experiments with the five
glucose meters and the laboratory reference method on the
same specimens and to prepare a series of samples covering the
whole concentration range (2.20 mmol/1 —28.80 mmol/1).
A 120 ml source specimen was collected in vacutainer tubes
containing lithium heparin (Venoject, Terumo Corp., Tokyo,
Japan) by venipuncture from one healthy volunteer. Whole
heparinised blood was used for analysis on all glucometers.
Plasma was used for the laboratory reference method.
To obtain samples in the high glucose concentration range
(> 10.00 mmol/1) specimens were supplemented with glucose
powder (Dextropur®, N.V. Maasindustrie, Antwerp). After
mixing and equilibration for two hours at room temperature,
all samples were simultaneously analysed on all the instruments
within an interval of 30 min. Samples in the low glucose con-
centration range (< 3.50 mmol/1) were obtained by letting the
source sample wait at room temperature until natural metabolic
depletion produced low glucose levels. Afterwards, all samples
were analysed within 30 min. Unspiked samples were used for
all experiments in the normoglycaemib range. In these cases the
interval between sampling prelevation and analysis was kept
lower than 30 mm to prevent metabolic changes.
All tests and manipulations were performed by a single oper-
ator.
Instruments
We evaluated
the Reflolux S (Boehringer Mannheim Canada Ltd., Dorval,
Quebec),
the Accutrend (Boehringer Mannheim Canada Ltd., Dorval,
Quebec),
the One Touch II (Lifescan inc., Mountain View, CA 94043),
the Glucometer Gx (Ames Division, Miles Laboratories, Eto-
bicoke, Ontario) and
the Glucocard (Menarini Diagnostics, DIC Kyoto, Kagaku Co.,
Ltd., Japan).
% t—.
Table 1 summarizes the main characteristics of the instruments.
The monitors with their respective strips were used according
to the manufacturer's instructions.
For comparison, we determined glucose concentrations in
plasma using the hexokinase method (RA 1000, Technicon
Instruments Corp., Tarrytown, New York, Technicon Diagnos-
tics Glucose reagent, product no. Tl 1-1832). This method is
the generally accepted reference method for the determination
of glucose in body fluids by spectrophotometric analysis (2).
Tab. 1. Main characteristics of the evaluated blood glucose meters
Measuring
range
Accutrend 1.3-33.3 mmol/1
Reflolux S 0.6-27 mmol/1
One Touch II 0 -33.3 mmol/1
Glucometer Gx 1.4- 22.2 mmol/1
Glucocard 2.2-27.8 mmol/1
Calibration Reaction
time
lot-specific 20 s
calibration
strip
lot-specific 120 s
calibration
strip
program number 45 s
program number 50 s
lot-specific 60 s
calibration
strip
Reaction
principle
glucose-oxidase/
peroxidase
glucose-oxidase/
peroxidase
glucose-oxidase/
peroxidase
glucose-oxidase/
peroxidase
glucose-oxidase/
ferricyanide,
conductivity
measurement
Memory
50 results
20 results
250 results,
in 9 groups
10 results
last result
v
' »
Strips
non-wiping,
visual reading
restricted
dry-blotting,
visual colour
comparison
for all
concentrations
non-wiping,
no visual
reading
dry-blotting,
visual colour
comparison
for all
concentrations
non-wiping,
no visual
reading
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Qual i ty control materials
We used the aqueous-based controls
'Reflolux II Control' (Boehringer Mannheim) low and high
concentration,
'Accutrend Control' (Boehringer Mannheim) normal and high
concentration,
One Touch Normal Control' (Lifescan Inc.),
'Dextro-check Control' normal, low and high control (Ames
Division).
Control solutions for the Glucocard were not available at the
time of evaluation.
Data analysis
The relation between the results obtained with the blood glucose
monitors for whole blood and the laboratory method for
plasma was calculated by linear regression analysis according
to Deming (3). The Pearson rank correlation coefficient was
calculated for the corresponding quantities.
The Fisher test was used to determine the significance of ob-
served differences (4).
Evaluation methods
Precision of the glucose meters
Reproducibility
Samples for the low and normal concentration range were the
same for all meters; in the high concentration range (> 13.9
mmol/1) different samples were used. We determined the pre-
cision of each analytical system by repeatedly (n = 10) meas-
uring the whole blood glucose concentrations in the normal,
low and high concentration ranges.
The coefficient of variation (CV) was calculated for each mon-
itor.
Within-day precision
Within-day precision was determined by a ten-fold glucose
measurement with four of the five glucose monitors, each with
its corresponding aqueous glucose control solution. Control
solutions for Glucocard were not yet available at the time of
evaluation. Aqueous glucose solutions were used instead of
blood specimens because of the stability of the former. CV's
were calculated for each monitor.
Between-day precision
Between-day precision for four of the glucose meters (Reflolux
S, Accutrend, One Touch II, and Glucometer Gx) was deter-
mined by measuring each manufacturer's corresponding aque-
ous glucose control solution on eight consecutive days. CV's
were calculated for each monitor.
Variation in the size of blood sample applied on the
test strip
The sample volume required to properly cover the test pad of
most strips was 25 μΐ. For the Glucocard test strips the volume
was fixed at 5 μΐ due to the strip design.
To evaluate the effect of under^ and overloading of the strips,
the pads were covered with 10,15, 25, 50, 75 or 100 ul of whole
blood. All samples were taken from a single pool with known
glucose content. The strips were incubated with whole hepar-
inised blood with glucose concentrations in the normal, low
and high ranges, and read according to the manufacturer's
instructions with Refiolux S, Accutrend, One Touch II, Glu-
cometer Gx. As a minimum volume for Reflolux S, One Touch
II, Glucometer Gx ΙΟ μΙ was used; Accutrend Glucose strips
were insufficiently covered by volumina less than 15 μΐ.
The mean and standard deviation (S. D.) of ten consecutive
determinations were calculated and the Fisher test was used to
determine the significance of the observed differences
(p < 0.05).
Variation in blood incubat ion period
The effect of variation in incubation time was evaluated by
incubating the strips for periods shorter than or exceeding the
incubation time prescribed by the manufacturer. Following the
manufacturer's guidelines the blood was incubated on the test
pad for 60 s (Reflolux S), 20 s (Accutrend), 30 s (glucometer
Gx). It was technically impossible to change the incubation
time for the One Touch and Glucocard strips, because count-
down is started automatically when blood is applied on the
strip which has already been inserted into the instrument. Var-
ying incubation times were evaluated for three glucose concen-
tration ranges. For each apparatus all samples used for variable
incubation time were taken from one pool with known glucose
concentration.
The mean (n = 10) and S. D. were calculated and the Fischer
test was used to determine the significance of the observed
differences at a p < 0.05 level.
Variation in colour s tabi l i ty
Variation in colour stability was evaluated by measuring the
same glucose strip at time 0, 10 min, 20 min, 30 min, 1 hour,
2 hours, 4 hours, 8 hours, and 24 hours after colour develop-
ment.
Glucose concentrations in the normal, low and high ranges
were used. Strips of the Reflolux S, Accutrend and Glucometer
Gx were stored in their usual containers at room temperature.
For One Touch II and Glucocard glucose strips it was techni-
cally impossible to repeat the reading.
Agreement between methods
Thirty samples containing normal, low and high blood glucose
concentrations in the range of 2.5 —16.7 mmol/1 were examined
on each of the five glucose meters and compared with the
laboratory reference method (hexokinase method performed on
RA 1000, Technicon Instruments Corp., Tarrytown, New York).
For instrument reasons, whole heparinised blood was used on
the glucose meters and plasma was used for the reference
method. The correlation of the glucometer results with the
reference method was calculated.
Error grid analysis
The error grid analysis describes the clinical accuracy of self-
monitoring blood glucose systems over the entire range of blood
glucose values, taking into account the absolute value of the
instrument-generated blood glucose concentration, the absolute
value of blood glucose concentration measured by the reference
method, the relative difference between these two values and
the clinical significance of the difference (5). Percent deviation
may be a clinically more useful measurement, but only if there
is a consistent percentage difference which is clinically mean-
ingful over the entire range of the data being reported.
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 12
832 Devreese and Leroux-Roels: Self-monitoring of blood glucose
Error grid analysis for the evaluation of the clinical implication
of patient-generated blood glucose values distinguishes five
zones of varying degrees of accuracy of glucose estimations:
Zone A: glucose values that deviate from the reference method
by less than 20%. These values are clinically accurate since they
would lead to correct treatment decisions;
Zone B: values that deviate from the reference method by
> 20% but would lead to benign or no treatment errors;
Zone C: values that would result in overcorrecting acceptable
blood glucose levels. Such treatment might cause the actual
blood glucose to fall below 3.9 mmol/1 (70 mg/dl) or rise above
10mmol/l (180 mg/dl);
Zone D: dangerous failure to detect and treat;
Zone E: erroneous treatment zone.
An error grid analysis of 30 data-sets of each of the five glucose
meters compared with the hexokinase method (RA 1000, Tech-
nicon Instruments Corp., Tarrytown, New York) was per-
formed.
Influence of haematocri t
on blood glucose measurement
Heparinised venous blood with normal and high glycaemic
values was centrifugated (3000 min"1, 10 min) and packed cells
and plasma were reconstituted at different ratios to obtain six
samples with haematocrit levels ranging from 0.15 — 0.60. Glu-
cose concentrations were measured in duplicate on the five
glucometers.
Haematocrit values were determined by a Coulter Counter
(Coulter JT 3 Haematology System, Coulter Elektronics Inc.,
Luton, England).
CV are between 2 and 6%, except for the Glucometer
Gx, where the CV in the normal range is 10.5% and
in the high concentration range 7.8%.
Within-day precision ' r
In the normal concentration range the lowest CV
(1.6%) is seen for One Touch II; Glucometer Gx has
a CV of 7.3%. The other results are shown in table 3.
Tab. 3. Within-day precision with aqueous control solutions
Mean
(mmoi/I)
CV
Accutrend
Control 1
Control 2
Reflolux S
Control 1
Control 2
One Touch II
Normal Control
Glucometer Gx
Normal Control
Low Control
High Control
3.4
9.8
2.7
15.8
5.9
5.4
2.4
13.0
2.2
2.7
5.6
5.8
1.6
10.5
9.5
n = 10
Precision of the glucose meters
Reproducibility
Reproducibility of glucose determination in the low,
normal and high concentration range is shown in
table 2.
Tab. 2. Reproducibility of five glucose meters
Accutrend
Reflolux S
One Touch II
Glucometer Gx
Glucocard
Mean
(mmol/1)
2.9
4.7
28.8
2.5
4.4
19.4
1.35
4.0
22.0
2.2
6.4
15.1
3.5
4.4
13.9
CV
2.8
3.6
5.2
6.0
5.6
2.7
5.5
2.0
1.5
4.6
10.5
7.8
4.8
1.7
3.0
Between-day precision
As shown in table 4> CV'S for between-day precision
ranged from 3.6% to 9.9%.
Tab. 4. Between-day precision with aqueous control solutions
Accutrend
control 1
Reflolux S
Control 1
One Touch II
Normal Control
Glucometer Gx
Normal Control
Mean
(mmol/1)
3.4
2.6
5.9
4.8
CV
(%)
5.0
3.6
4.0
9.9
n = 10
n = 8
Variation in the size
of the blood sample applied on the strip
Underloading had a statistically significant effect on
blood glucose concentrations for Accutrend (normal,
low, and high concentration ranges), Reflolux S (nor-
mal and high concentration ranges), One Touch II
(normal concentration range) and Glucometer Gx
(low concentration range).
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Fig. la— d. Influence of variations in the size of blood sample
on the glucose measurements.
a: Accutrend, b: Reflolux S,
c: One Touch II, d: Glucometer Gx.
The arrow indicates the usual blood volume (25 μΐ)
Error bars indicate ± S.D. (n = 10).
Asterisks indicate results that differed significantly
(p < 0.05, Fisher test) from those obtained at the
appropriate (arrowed) blood volumes.
Overloading the strip had a statistically significant
effect for One Touch II in the normal and low con-
centration ranges (see fig. la—d).
Variation in blood incubation period
Incubation the test strips with blood for periods
shorter than those recommended had a statistically
significant effect on blood glucose concentrations for
all meters (see fig. 2a —c).
Incubating the Accutrend Glucose strips 40 s longer
than recommended had no statistically significant ef-
fect for the low and normal glucose concentration
ranges, but gave significant differences in the high
glucose concentration range. Incubating the Haemo-
Glukotest 20-800 R strips (Reflolux S) for periods
two or two-and-a-half times as long as the prescribed
incubation time induced significantly (p < 0.05) dif-
ferent results. Incubating the Glucostix (Glucometer
Gx) longer than the recommended incubation time
also produced significantly different results. Extend-
ing the incubation time of the Glucostix for five
seconds already induced significantly different results
in the high concentration range. Longer incubation
made the strip technically unreadable because of the
very dark colour development.
Variation in colour development
Variation in colour development is represented in
table 5. After colour development of the strip, we
noted further changes in measured blood glucose con-
centrations during the following half-hour. The
changes were small for Reflolux S and Glucometer
Gx. However, during the four hours following colour
development the blood glucose concentrations meas-
ured by Accutrend were very unstable, and changes
up to 205% were noted in the normoglycaemic range.
Agreement between methods
Comparison of the glucose meter results and those
obtained with the hexokinase method are shown in
table 6. The slope of the regression line approached
Tab. 5. Effect of storage on strip colour
Time after reading
(min)
0**
10
20
30
60
120
240
480
1440
\ Accutrend
N*
100
179
195
205
194
164
91
89
87
L
100
186
248
270
302
282
151
146
142
H
100
120
123
123
105
86
40
33
36
Reflolux S
N
100
106
108
108
107
107
106
106
105
L
100
105
105
105
107
103
102
102
103
H
100
112
111
110
110
109
108
107
104
Glucometer Gx
N
100
79
77
75
76
73
64
65
61
L
100
72
71
69
65
65
60
59
57
H
100
105
109
111
103
100
98
98
94
* N, L, H: samples with normal (N), low (L) and high (H) glucose concentrations were used.
** glucose concentration at time 0 = 100%
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Tab. 6. Comparison of glucose meters and hexokinase-method
Accu trend
Reflolux S
One Touch II
Glucometer Gx
Glucocard
Correlation
coefficient
Γ
0.988
0.992
0.942
0.986
0.976
Regression analysis
y = ax + b*
a b Sxy**
0.839 0.203 0.453
1.132 -1.085 0.374
0.907 0.084 0.830
1.047 -0.576 0.453
1.184 -1.038 0.687
* Linear regression of y (glucoraeter)
method) + b
** Standard error of y estimated
η = 30
= ax (hexokinase-
1.0 in three of the five glucometers. For Accutrend
the slope was 0.839, for Glucocard the slope was
1.184.
Error grid analysis
Error grid analysis results show that all five instru-
ments generated clinically correct (zone A and B)
glucose values. All Accutrend, Reflolux S and One
Touch II glucose values are situated in zone A, 8 out
of the 30 (26.7%) results of Glucometer Gx and 2
out of 30 (6.7%) of the Glucocard are situated in
zone B.
Influence of haematocrit on blood glucose
measurement
The influence of haematocrit values on blood glucose
concentrations is depicted in figure 3a—e.
The change in blood glucose concentrations induced
by variations in the haematocrit was less than 10%
for measurements performed with Accutrend and
Glucocard in the normoglycaemic range. For Reflolux
S in the normoglycaemic range an increase of 45%
in blood glucose concentration was noted for decreas-
ing haematocrit values. For One Touch II and Glu-
cometer Gx a decrease of 40—60% in blood glucose
concentration is noted on increasing haematocrit.
In the high glucose concentration range there is for
all meters, a decrease in blood glucose concentration
on increasing haematocrit values, but the effect was
small for Accutrend and Glucocard. The Glucometer
Gx was most sensitive to increased haematocrit val-
ues.
Discussion
For this evaluation of 5 glucose meters designed for
the self-monitoring of blood glucose concentrations,
we have used whole heparinised blood from a single
healthy donor for ethical and practical reasons
mainly; further, we wished to reduce biological vari-
ability as much as possible and we hoped to eliminate
the influence of haematocrit in the measurement of
glucose concentration. Anticoagulants can affect the
measurements of self-monitoring blood glucose me-
ters. Whereas major influences have been described
for fluoride-oxalate, the interference of heparin seems
to be small (6).
Our evaluation shows that the newer glucose meters
are easier to use, but that their analytical performance
is not significantly better than that of their predeces-
sors (7 — 9). Because the primary concern in diabetes
control is the detection of changes in blood glucose
concentration over time, methods for the self-moni-
toring of blood glucose concentration should have
small CV's (10). The five glucose meters tested pro-
duced precise results as demonstrated by CV values
between 1.5 and 6.0. The CV's of Glucometer Gx are
higher than those of the other four instruments. Glu-
cometer II, the predecessor of Glucometer Gx, dis-
played similar characteristics (10, 11).
To evaluate the reproducibility in the normoglycaemic
concentration range, the same whole blood sample
was used for all meters. The CV found for Glucometer
Gx was 10%, and the glucose value measured with
the Glucometer Gx was about 30% higher than that
measured with the other instruments. Consequently,
the value obtained with this instrument reached the
critical glucose concentration for glycaemia control
in diabetic patients. Similar results have been de-
scribed for the Glucometer II (12).
We also found that aqueous calibration solutions in-
tended for one strip system cannot be used for an-
other. This may be due to the presence in these so-
lutions of stabilisers or preservatives that interfere
with the detection reaction on the strip.
Variables such as sample volume, blood incubation
time and colour stability of the strip may seriously
influence the blood glucose concentration was meas-
ured with the moaitors (13).
Sample volume is an important variable, since blood
loss through a fingerstick wound is unpredictable and
may or may not be sufficient for the planned meas-
urement. Glucocard only needs 5 μΐ blood to start
measuring, which makes the instrument very practical
for monitoring, especially of children.
Underloading the strip had statistically significant
effects on the measurement of normal blood glucose
concentrations for all meters. Only for results of the
One Touch strips were significant differences found
between normal blood sample volume (25 μΐ) and
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overloaded glucose strips in the normal and low con-
centration ranges. Problems with sample volume can-
not occur with Glucocard, because the required blood
volume is fixed at 5 μΐ according to the strip design.
Blood incubation time is critical, but with the most
recently developed glucose meters (Accutrend, One
Touch II, Glucocard) variations in incubation time
have become almost impossible.
After the colour of the strip developed, we noted only
small changes for Haemo-Glukotest 20-800R strips
and Glucostix, while colour development of the Ac-
cutrend Glucose strips was stable for less than 10
minutes. The Accutrend Glucose strips should, there-
fore, be read immediately after the prescribed incu-
bation time.
An additional advantage of Haemo-Glukotest 20-
800R strips and Glucostix is that it is possible to
assess the blood glucose value simultaneously by vi-
sual colour comparison over the entire range of meas-
urement by the meter.
Comparison of blood glucose measurements obtained
by the glucose meters with those measured by the
laboratory reference method, showed a very good
correlation. Good correlation coefficients between the
data sets do not permit evaluation of the clinical
accuracy of the data. Therefore, error grid analysis,
based on treatment goals, was performed to evaluate
the usefulness and clinical accuracy of the glucose
meters (5, 14). Our results show that all five glucose
meters produce clinically acceptable results.
There are several potential sources of errors when
blood glucose is determined with a test strip; even
when the technique is performed correctly there are
still factors that may induce errors. One of these is
the haematocrit value. An important group of subjects
with low haematocrit values are diabetic patients with
end-stage renal failure (15). The influence of haema-
tocrit is also important in pediatric monitoring.
Previous studies have demonstrated that glucose con-
centrations measured with strips overestimate the true
blood glucose concentration in diabetic patients with
low haematocrit, to an extent that may be clinically
significant (15,16). This may be due to an accelerated
and increased diffusion of plasma to the reagent pad
in a specimen with a reduced number of erythrocytes.
In the normoglycaemic range the results obtained with
Accutrend and Glucocard are not influenced by even
extreme haematocrit values. For Reflolux S in the
normoglycaemic range an increase in blood glucose
concentration is noted for decreasing haematocrit val-
ues. For One Touch II and Glucometer Gx an obvious
decrease in blood glucose concentration is noted for
increasing haematocrit.
In the high glucose concentration range there is a
decrease in blood glucose concentration for increasing
haematocrit values for all meters, but the effect is
small for Accutrend and Glucocard. The results of
Glucometer Gx were most influenced by high hae-
matocrit values.
In contrast to home-monitoring or the hospital bed-
side glucose analysis, our evaluation of the instru-
ments was performed under optimal, privileged work-
ing conditions. The tests were performed by a single
operator trained in the manipulation of analytical
equipment in general and on the test equipment in
particular. Tests were performed in one room with a
constant ambient temperature. Daily quality controls
were performed and pipettes were used to control
sample volumes and application conditions.
Excellent performance of an instrument in the hands
of trained laboratory personnel is no guaranty for a
similar performance when the instruments used out-
side the laboratory by less well trained or untrained
operators (7, 10, 17, 18).
Each of the monitors was easy to use and had clear
instructions supplied by the manufacturer. Chances
for manipulation errors are minimal with One Touch
II and Glucocard (12). Systems where wiping off the
blood drop is not necessary, such as Accutrend, One
Touch II and Glucocard, are more practical and less
time-consuming.
The user-friendliness, cost, and variables involved in
the technique — such as sample volume, incubation
time, use of test strips, and blotting the strip-should
be considered in the choice of an instrument. Accord-
ing to our results one may be confident that Reflolux
S, Accutrend, One Touch II and Glucocard will pro-
vide sufficient accuracy for routine use outside the
laboratory when motivated users, patients and nurses
are properly trained and perform all manipulations
with care.
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